
Orthogonal, Kwame Ulmer on the Value of AdvaMed Membership
At AdvaMed, we’re proud to be recognized for our work on behalf of the medtech community – and we’re especially grateful when that recognition comes from respected voices like Kwame…
AdvaMed®’s Medtech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.
At AdvaMed, we’re proud to be recognized for our work on behalf of the medtech community – and we’re especially grateful when that recognition comes from respected voices like Kwame…
Join thousands of industry leaders October 5-8, 2025, in San Diego, California for direct access to hundreds of hours of timely medtech education, networking with industry leaders and CEOs, and…
AdvaMed President and CEO Scott Whitaker describes the importance of engaging patients in every stage of medtech innovation.
AdvaMed President and CEO Scott Whitaker is leading the call for a reciprocal “zero-for-zero” tariff agreement on medtech, urging the U.S. and its trading partners to eliminate tariffs on essential,…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Flexibility on tariffs is critical to maintaining medtech as the backbone of the U.S. health care system and an American economic success story.
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Nominate a medtech pioneer for AdvaMed®’s 2025 Lifetime Achievement Award to celebrate their contributions to the health care industry!
We took time to reflect on another extraordinary year in the medtech industry and the tremendous strides we’ve made together. Our 2024 AdvaMed® Annual Report highlights our key policy wins,…
If you have media inquiries, please contact:
Cody Uhing, Director, Communications & Media Relations, 202-316-1423
AdvaMed® filed an amicus brief in the case of Smith v. Terumo BCT, Inc. The case concerns whether the court should create a cause of action for asymptomatic plaintiffs, permitting…
Join over 500 medical technology companies as a member of one of the most effective trade associations in Washington, D.C.